Read + Share
Amedeo Smart
Independent Medical Education
Heitz F, Lakis S, Harter P, Heikaus S, et al. Cell-free tumor DNA, CA125 and HE4 for the objective assessment of tumor burden in patients with advanced high-grade serous ovarian cancer. PLoS One 2022;17:e0262770.PMID: 35130283
Email
LinkedIn
Facebook
Twitter
Privacy Policy